CellREDM and PBSerum 2026 Launch

Neu Era proudly marked an important milestone in its continued commitment to advancing regenerative aesthetic medicine with the official launch of CellREDM and PBSerum HA2.0 in Singapore.

Hosted at Pan Pacific Orchard, the launch brought together leading aesthetic physicians, industry partners, medical experts and international speakers for an evening dedicated to the latest developments in skin regeneration, tissue remodelling and clinically driven aesthetic innovation.

The event introduced two complementary technologies that reflect Neu Era’s focus on bringing scientifically differentiated and clinically relevant solutions to medical professionals across the region.

CellREDM represents a new approach to regenerative aesthetics through the use of human acellular dermal matrix technology. By providing an extracellular matrix-based environment containing key structural components, CellREDM is designed to support tissue integration and improve overall skin quality, texture and structural integrity. The launch provided physicians with an in-depth understanding of its scientific foundation, clinical applications, treatment protocols and potential role within combination-based regenerative treatment strategies.

Alongside CellREDM, Neu Era also showcased PBSerum HA2.0, an advanced recombinant enzyme system developed for targeted tissue remodelling. The technology offers physicians a differentiated approach to addressing aesthetic concerns associated with altered tissue structure, including fibrosis, scars, skin laxity and other indications where precise enzymatic remodelling may be beneficial.

Throughout the evening, invited experts shared their clinical experience, treatment philosophies and practical approaches through scientific presentations, case discussions and protocol-based education. The programme was designed not only to introduce the technologies, but also to provide physicians with a deeper understanding of how they can be integrated safely and effectively into modern aesthetic practice.

The launch reflects Neu Era’s broader mission to go beyond product distribution by building a strong ecosystem of medical education, physician training, clinical support and long-term partnership. Through its regional network and training initiatives, Neu Era remains committed to supporting doctors with the knowledge, resources and technologies required to deliver high standards of patient care.

By introducing CellREDM and PBSerum HA2.0 to the Singapore market, Neu Era continues to strengthen its position as a trusted partner in the advancement of regenerative and aesthetic medicine across Asia.

Two advanced technologies. One new standard in regenerative aesthetics.